Trials / Completed
CompletedNCT04173364
Interscalene Block and Dysfunction Diaphragmatic
Interscalene Block and Dysfunction Diaphragmatic: Effect of Low Volume of Ropivacaine 0,1%. A Randomised, Controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study seeks to show that interscalene injection of a small volume (\<8ml) of ropivacaine at a low concentration (0.1%) reduces the frequency of hemi-diaphragmatic paresis compared to low volume injection at the standard concentration (0.5%) in patients undergoing arthroscopic shoulder surgery with ISB.
Detailed description
It's a prospective monocentric randomized controlled clinical trial in 2 parallel groups in double blind. the study concerns patients undergoing arthroscopic shoulder surgery with ISB. The study seeks to show that interscalene injection of a small volume (\<8ml) of ropivacaine at a low concentration (0.1%) reduces the frequency of hemi-diaphragmatic paresis compared to low volume injection at the standard concentration (0.5%) in patients undergoing arthroscopic shoulder surgery with ISB. Randomization in one of the two arms: * Experimental group: \<8ml ropivacaine 0.1%. * Control group: \<8mL of ropivacaine 0.5%. Evaluation of diaphragmatic stroke by ultrasound and ventilatory function by spirometry and snip test before performing the ISB, then after installation of the ISB. Performing the surgical procedure under general anesthesia assessment of postoperative analgesia and patient satisfaction during the following 48 hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine 0.5% Injectable Solution | Injectable solution of ropivacaine 0.5% |
| DRUG | Ropivacaine 0.1% Injectable Solution | Dilution of ropivacaine to the concentration of 0.1% |
Timeline
- Start date
- 2019-10-29
- Primary completion
- 2020-09-21
- Completion
- 2020-09-21
- First posted
- 2019-11-21
- Last updated
- 2022-06-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04173364. Inclusion in this directory is not an endorsement.